NASDAQ: LUCD - Lucid Diagnostics Inc.

Rentabilität für sechs Monate: -12.11%
Sektor: Healthcare

Aktionsplan Lucid Diagnostics Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma (EAC). It offers EsoCheck, a cell collection device to prevent EAC deaths; and EsoGuard, an Esophageal DNA Test. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

Выручка 0.0005
EBITDA -0.0044
Число акций ао 0.04176 млрд
P/S 375.02
P/BV 3.43
EV/EBITDA 0.0354
Цена ао 0.99
ISIN US54948X1090
Сайт https://www.luciddx.com
Валюта usd
IPO date 2021-10-14
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Preisänderung pro Tag: -2.3% (0.8291)
Preisänderung pro Woche: +3.42% (0.7832)
Preisänderung pro Monat: +4.15% (0.7777)
Preisänderung über 3 Monate: -1.36% (0.8212)
Preisänderung über sechs Monate: -12.11% (0.9216)
Preisänderung pro Jahr: -36.22% (1.27)
Preisänderung seit Jahresbeginn: -37.21% (1.29)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 24.08 1
P/BV -25.3 0
P/E 0 0
EV/EBITDA -1.19 0
Gesamt: 3.38

Effizienz

Name Bedeutung Grad
ROA, % -193.13 0
ROE, % 2278.93 10
Gesamt: 3.33

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.3318 10
Gesamt: 7.8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 385.6 10
Rentabilität Ebitda, % 945.07 10
Rentabilität EPS, % 955.46 10
Gesamt: 10
Weitere Details

Institutionen Volumen Aktie, %
Luminus Management, LLC 773246 1.6
Vanguard Group Inc 332391 0.69
Nantahala Capital Management, LLC 299396 0.62
Bridgeway Capital Management, Inc. 135000 0.28
Geode Capital Management, LLC 131871 0.27
Verition Fund Management, LLC 36166 0.07
Geneos Wealth Management, Inc. 33850 0.07
LPL Financial LLC 32630 0.07
Citadel Advisors Llc 29639 0.06
Blackrock Inc. 23453 0.05



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Lishan Aklog M.D. Chairman & CEO 300k 1966 (58 Jahre)
Dr. Sanford D. Markowitz M.D., Ph.D. Co-Founder, Strategic Advisor & Member of the Medical Advisor Board 14.54k
Dr. Joseph Willis M.D. Cofounder, Strategic Advisor & Member of Medical Advisory Board N/A
Dr. Amitabh Chak M.D. Co-Founder, Strategic Advisor & Member of Medical Advisory Board N/A
Richard D. Yazbeck Chief Technology Officer N/A
Dr. Suman M. Verma M.D., Ph.D. Chief Scientific Officer N/A
Dr. Brian J. deGuzman M.D. Chief Compliance Officer N/A 1965 (59 Jahre)
Mr. Michael Adam Gordon General Counsel & Secretary 250k 1975 (49 Jahre)
Mr. Shaun M. O'Neill M.B.A. President & COO 1982 (42 Jahr)
Dr. Deepika A. Lakhani Ph.D. Chief Regulatory & Quality Officer

Adresse: United States, New York. NY, 360 Madison Avenue - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.luciddx.com